Literature DB >> 30882850

The Surprisingly Positive Association Between Obesity and Cancer Immunotherapy Efficacy.

William J Murphy1,2, Dan L Longo3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30882850     DOI： 10.1001/jama.2019.0463

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  30 in total

Review 1.  Microbiome, bile acids, and obesity: How microbially modified metabolites shape anti-tumor immunity.

Authors:  Laura M Sipe; Mehdi Chaib; Ajeeth K Pingili; Joseph F Pierre; Liza Makowski
Journal:  Immunol Rev       Date:  2020-05       Impact factor: 12.988

2.  Excess weight and anti-PD-1 immune checkpoint inhibitor's outcomes in non-small cell lung cancer.

Authors:  Jacobo Rogado; Fernando Pozo; Kevin Troulé; José Miguel Sánchez-Torres; Nuria Romero-Laorden; Rebeca Mondejar; Olga Donnay; Anabel Ballesteros; Vilma Pacheco-Barcia; Javier Aspa; Fátima Al-Shahrour; Arantzazu Alfranca; Ramon Colomer
Journal:  Clin Transl Oncol       Date:  2022-07-23       Impact factor: 3.340

3.  A Bayesian phase I/II biomarker-based design for identifying subgroup-specific optimal dose for immunotherapy.

Authors:  Beibei Guo; Yong Zang
Journal:  Stat Methods Med Res       Date:  2022-02-22       Impact factor: 2.494

Review 4.  Expected and paradoxical effects of obesity on cancer treatment response.

Authors:  Marco Gallo; Valerio Adinolfi; Viola Barucca; Natalie Prinzi; Valerio Renzelli; Luigi Barrea; Paola Di Giacinto; Rosaria Maddalena Ruggeri; Franz Sesti; Emanuela Arvat; Roberto Baldelli; Emanuela Arvat; Annamaria Colao; Andrea Isidori; Andrea Lenzi; Roberto Baldell; M Albertelli; D Attala; A Bianchi; A Di Sarno; T Feola; G Mazziotti; A Nervo; C Pozza; G Puliani; P Razzore; S Ramponi; S Ricciardi; L Rizza; F Rota; E Sbardella; M C Zatelli
Journal:  Rev Endocr Metab Disord       Date:  2020-10-06       Impact factor: 6.514

Review 5.  Dissecting the biology of allogeneic HSCT to enhance the GvT effect whilst minimizing GvHD.

Authors:  Bruce R Blazar; Geoffrey R Hill; William J Murphy
Journal:  Nat Rev Clin Oncol       Date:  2020-04-20       Impact factor: 66.675

6.  Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity.

Authors:  Alison E Ringel; Jefte M Drijvers; Gregory J Baker; Alessia Catozzi; Juan C García-Cañaveras; Brandon M Gassaway; Brian C Miller; Vikram R Juneja; Thao H Nguyen; Shakchhi Joshi; Cong-Hui Yao; Haejin Yoon; Peter T Sage; Martin W LaFleur; Justin D Trombley; Connor A Jacobson; Zoltan Maliga; Steven P Gygi; Peter K Sorger; Joshua D Rabinowitz; Arlene H Sharpe; Marcia C Haigis
Journal:  Cell       Date:  2020-12-09       Impact factor: 41.582

Review 7.  The Role of Malnutrition and Muscle Wasting in Advanced Lung Cancer.

Authors:  Rishi Jain; Chris Coss; Peter Whooley; Mitch Phelps; Dwight H Owen
Journal:  Curr Oncol Rep       Date:  2020-05-15       Impact factor: 5.075

Review 8.  Cell Intrinsic and Systemic Metabolism in Tumor Immunity and Immunotherapy.

Authors:  Michael F Coleman; Alyssa J Cozzo; Alexander J Pfeil; Suhas K Etigunta; Stephen D Hursting
Journal:  Cancers (Basel)       Date:  2020-04-01       Impact factor: 6.639

9.  The future of cancer immunotherapy: microenvironment-targeting combinations.

Authors:  Yonina R Murciano-Goroff; Allison Betof Warner; Jedd D Wolchok
Journal:  Cell Res       Date:  2020-05-28       Impact factor: 25.617

10.  Association between body mass index, dosing strategy, and efficacy of immune checkpoint inhibitors.

Authors:  Murtaza Ahmed; Mitchell S von Itzstein; Thomas Sheffield; Shaheen Khan; Farjana Fattah; Jason Y Park; Vinita Popat; Jessica M Saltarski; Yvonne Gloria-McCutchen; David Hsiehchen; Jared Ostmeyer; Saad A Khan; Nazima Sultana; Yang Xie; Quan-Zhen Li; Edward K Wakeland; David E Gerber
Journal:  J Immunother Cancer       Date:  2021-06       Impact factor: 13.751
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.